Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia

Blood

Volumn 126, Issue 22, 2015, Pages 2484-2490

  Churpek, Jane E ^a   Pyrtel, Khateriaa ^b   Kanchi, Krishna Latha ^c   Shao, Jin ^b   Koboldt, Daniel ^b,c   Miller, Christopher A ^c   Shen, Dong ^d   Fulton, Robert ^c   O'Laughlin, Michelle ^c   Fronick, Catrina ^c   Pusic, Iskra ^c   Uy, Geoffrey L ^c   Braunstein, Evan M ^e   Levis, Mark ^e   Ross, Julie ^f   Elliott, Kevin ^b   Heath, Sharon ^b   Jiang, Allan ^c   Westervelt, Peter ^b,c   DiPersio, John F ^b,c   Link, Daniel C ^b,c   Walter, Matthew J ^b,c   Welch, John ^b,c   Wilson, Richard ^b,c   Ley, Timothy J ^b,c   Godley, Lucy A ^a   Graubert, Timothy A ^g   more..

^a SECTION OF HEMATOLOGY ONCOLOGY   (United States)

^b USA   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MEDIMMUNE   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COHESIN; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR RUNX1; ASXL1 PROTEIN, HUMAN; DNA BINDING PROTEIN; PDS5B PROTEIN, HUMAN; REPRESSOR PROTEIN; RUNX1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; CHILD; DISEASE PREDISPOSITION; EXOME; FAMILIAL MYELODYSPLASIA; FRAMESHIFT MUTATION; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOMICS; GERM LINE; HEMATOPOIESIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIDDLE AGED; MYELODYSPLASTIC SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SOMATIC CELL; SOMATIC MUTATION; VERY ELDERLY; YOUNG ADULT; ACUTE MYELOID LEUKEMIA; ADOLESCENT; CLINICAL TRIAL; FEMALE; GENETIC DISORDER; GENETICS; GERMLINE MUTATION; MALE; MOLECULAR GENETICS; MULTICENTER STUDY; NUCLEOTIDE SEQUENCE;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; CHILD; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; EXOME; FEMALE; GENETIC DISEASES, INBORN; GERM-LINE MUTATION; HEMATOPOIESIS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MYELODYSPLASTIC SYNDROMES; NEOPLASM PROTEINS; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS;

EID: 84948976984     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-04-641100     Document Type: Article

References (42)

1. Song WJ, Sullivan MG, Legare RD, et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet. 1999; 23(2):166-175.
2. National Center for Biotechnology Information. OMIM: online Mendelian inheritance in man. http://www.ncbi.nlm.nih.gov/omim, article #601399. Accessed April 15, 2015.
3. Smith ML, Cavenagh JD, Lister TA, Fitzgibbon J. Mutation of CEBPA in familial acute myeloid leukemia. N Engl J Med. 2004;351(23):2403-2407.
4. Sellick GS, Spendlove HE, Catovsky D, Pritchard-Jones K, Houlston RS. Further evidence that germline CEBPA mutations cause dominant inheritance of acute myeloid leukaemia. Leukemia. 2005;19(7):1276-1278.
5. National Center for Biotechnology Information. OMIM: online Mendelian inheritance in man. http://www.ncbi.nlm.nih.gov/omim, article #116897. Accessed April 15, 2015.
6. Hahn CN, Chong CE, Carmichael CL, et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet. 2011;43(10):1012-1017.
7. Hsu AP, Sampaio EP, Khan J, et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 2011;118(10):2653-2655.
8. Ostergaard P, Simpson MA, Connell FC, et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet. 2011; 43(10):929-931.
9. Dickinson RE, Griffin H, Bigley V, et al. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood. 2011;118(10):2656-2658.
10. Polprasert C, Schulze I, Sekeres MA, et al. Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms. Cancer Cell. 2015;27(5):658-670.
11. Noris P, Favier R, Alessi MC, et al. ANKRD26-related thrombocytopenia and myeloid malignancies. Blood. 2013;122(11):1987-1989.
12. Kirwan M, Walne AJ, Plagnol V, et al. Exome sequencing identifies autosomal-dominant SRP72 mutations associated with familial aplasia and myelodysplasia. Am J Hum Genet. 2012;90(5):888-892.
13. Zhang MY, Churpek JE, Keel SB, et al. Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy. Nat Genet. 2015;47(2):180-185.
14. Churpek JE, Garcia JS, Madzo J, Jackson SA, Onel K, Godley LA. Identification and molecular characterization of a novel 39 mutation in RUNX1 in a family with familial platelet disorder. Leuk Lymphoma. 2010;51(10):1931-1935.
15. Nissenblatt MJ, Bias W, Borgaonkar D, Dixon S, Cody RP. Familial erythroleukemia: four cases of the Diguglielmo syndrome in close relatives. Johns Hopkins Med J. 1982;150(1):1-9.
16. Lee EJ, Schiffer CA, Misawa S, Testa JR. Clinical and cytogenetic features of familial erythroleukaemia. Br J Haematol. 1987;65(3):313-320.
17. Hsu AP, Johnson KD, Falcone EL, et al. GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome. Blood. 2013;121(19):3830-3837, S3831-3837.
18. Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368(22):2059-2074.
19. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754-1760.
20. Koboldt DC, Zhang Q, Larson DE, et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012;22(3):568-576.
21. Li H, Handsaker B, Wysoker A, et al; 1000 Genome Project Data Processing Subgroup. The sequence alignment/map format and SAMtools. Bioinformatics. 2009;25(16):2078-2079.
22. National Center for Biotechnology Information. dbSNP: database of single nucleotide polymorphisms. http://www.ncbi.nlm.nih.gov/ SNP, build 135. Accessed April 15, 2015.
23. National Heart, Lung, and Blood Institute. EXP: grand opportunity exome sequencing project. https://esp.gs.washington.edu/drupal, ESP6500. Accessed April 15, 2015.
24. 1000 Genomes. A deep catalog of human genetic variation. http://www.1000genomes.org. Accessed April 15, 2015.
25. National Center for Biotechnology Information. ClinVar: a freely accessible, public archive of reports of the relationships among human variations and phenotypes, with supporting evidence. http://www.ncbi.nlm.nih.gov/clinvar. Accessed April 15, 2015.
26. Leiden University Medical Center. LOVD: Leiden open-source variation database 3.0. http://www.lovd.nl/3.0/home. Accessed August 3, 2015.
27. Koboldt DC, Larson DE, Sullivan LS, et al. Exome-based mapping and variant prioritization for inherited Mendelian disorders. Am J Hum Genet. 2014;94(3):373-384.
28. Kim MS, An CH, Yoo NJ, Lee SH. Frameshift mutations of chromosome cohesion-related genes SGOL1 and PDS5B in gastric and colorectal cancers with high microsatellite instability. Hum Pathol. 2013;44(10):2234-2240.
29. Blighe K, Kenny L, Patel N, et al. Whole genome sequence analysis suggests intratumoral heterogeneity in dissemination of breast cancer to lymph nodes. PLoS One. 2014;9(12): e115346.
30. West RR, Hsu AP, Holland SM, Cuellar-Rodriguez J, Hickstein DD. Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation. Haematologica. 2014;99(2):276-281.
31. Bödör C, Renneville A, Smith M, et al. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival. Haematologica. 2012;97(6):890-894.
32. Yoshimi A, Toya T, Kawazu M, et al. Recurrent CDC25C mutations drive malignant transformation in FPD/AML. Nat Commun. 2014; 5:4770.
33. Walter MJ, Shen D, Ding L, et al. Clonal architecture of secondary acute myeloid leukemia. N Engl J Med. 2012;366(12):1090-1098.
34. Xie M, Lu C, Wang J, et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat Med. 2014;20(12):1472-1478.
35. Jaiswal S, Fontanillas P, Flannick J, et al. Agerelated clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371(26):2488-2498.
36. Genovese G, Kähler AK, Handsaker RE, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371(26):2477-2487.
37. Goldin LR, Kristinsson SY, Liang XS, Derolf AR, Landgren O, Bj örkholm M. Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes. J Clin Oncol. 2012;30(2):179-183.
38. Tung N, Battelli C, Allen B, et al. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer. 2015;121(1):25-33.
39. Zhang MY, Keel SB, Walsh T, et al. Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity. Haematologica. 2015; 100(1):42-48.
40. Thota S, Viny AD, Makishima H, et al. Genetic alterations of the cohesin complex genes in myeloid malignancies. Blood. 2014;124(11):1790-1798.
41. Welch JS, Ley TJ, Link DC, et al. The origin and evolution of mutations in acute myeloid leukemia. Cell. 2012;150(2):264-278.
42. Abkowitz JL. Clone wars-the emergence of neoplastic blood-cell clones with aging. N Engl J Med. 2014;371(26):2523-2525.